Chemotherapy of advanced colorectal carcinoma: fluorouracil alone vs. two drug combinations using fluorouracil, hydroxyurea, semustine, dacarbazine, razoxane, and mitomycin. A phase III trial by the Eastern Cooperative Oncology Group (EST: 1278). [electronic resource]
Producer: 19840820Description: 313-8 p. digitalISSN:- 0277-3732
- Adenocarcinoma -- drug therapy
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Clinical Trials as Topic
- Colonic Neoplasms -- drug therapy
- Dacarbazine -- therapeutic use
- Drug Administration Schedule
- Female
- Fluorouracil -- administration & dosage
- Gastrointestinal Diseases -- chemically induced
- Hematologic Diseases -- chemically induced
- Humans
- Hydroxyurea -- therapeutic use
- Male
- Middle Aged
- Mitomycins -- therapeutic use
- Random Allocation
- Razoxane -- therapeutic use
- Rectal Neoplasms -- drug therapy
- Semustine -- therapeutic use
- Time Factors
No physical items for this record
Publication Type: Clinical Trial; Comparative Study; Journal Article; Research Support, U.S. Gov't, P.H.S.
There are no comments on this title.
Log in to your account to post a comment.